MedPath

CATHFLO

CATHFLO

Approved
DIN Number

02245859

Drug Class

Human

Market Date

Sep 26, 2002

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245859
AIG Number0120086004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
B01AD02 ALTEPLASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationInstillation
AHFS Classification20:12.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ALTEPLASEActive
Strength: 2 MG / VIAL
Monograph: ALTEPLASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.